Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

  1. Montalban-Bravo, G.
  2. Takahashi, K.
  3. Patel, K.
  4. Wang, F.
  5. Xingzhi, S.
  6. Nogueras, G.M.
  7. Huang, X.
  8. Pierola, A.A.
  9. Jabbour, E.
  10. Colla, S.
  11. Gañan-Gomez, I.
  12. Borthakur, G.
  13. Daver, N.
  14. Estrov, Z.
  15. Kadia, T.
  16. Pemmaraju, N.
  17. Ravandi, F.
  18. Bueso-Ramos, C.
  19. Chamseddine, A.
  20. Konopleva, M.
  21. Zhang, J.
  22. Kantarjian, H.
  23. Futreal, A.
  24. Garcia-Manero, G.
Aldizkaria:
Oncotarget

ISSN: 1949-2553

Argitalpen urtea: 2018

Alea: 9

Zenbakia: 11

Orrialdeak: 9714-9727

Mota: Artikulua

DOI: 10.18632/ONCOTARGET.23882 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus